查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470765

醫院感染控制市場：按類型、適應症和最終用戶分類 - 全球預測 2024-2030

Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年醫院感染控制市場規模為342.6億美元，2024年達363.9億美元，預計2030年將達532億美元，複合年成長率為6.48%。

院內感染（HAI）控制是指醫療機構為預防和控制醫院和其他醫療機構收治的病人感染疾病而採取的系統方法和奉獻精神。這些感染疾病是由於接觸各種微生物（例如細菌、病毒、真菌和其他病原體）而發生的。這些措施涵蓋廣泛的策略，包括嚴格的衛生習慣、滅菌和消毒程序、個人防護工具(PPE) 的使用、感染疾病監測以及遵守侵入性操作和抗生素管理通訊協定。醫療保健環境中對感染疾病的認知不斷提高，加上對感染控制政策的迅速重視，正在推動市場成長。然而，在資源有限的環境中，與先進感染控制技術相關的高成本可能令人望而卻步。此外，滅菌和消毒流程的技術進步以及環保高效消毒劑的開發正在為製造商創造重大機會。

主要市場統計
基準年[2023] 342.6億美元
預測年份 [2024] 363.9億美元
預測年份 [2030] 532億美元
複合年成長率（%） 6.48%

透過類型診斷和測試設備的不斷技術進步提高效率

診斷和實驗室設備是識別和管理院內感染 (HAI) 的重要組成部分。此領域包括用於在臨床環境中快速檢測病原體的設備和套件。該設備利用聚合酵素鏈鎖反應（PCR）和酵素結合免疫吸附檢測法（ELISA）等先進技術，有助於早期診斷和監測感染，以便及時干預和治療。消毒產品在防止醫療機構內感染傳播方面發揮著至關重要的作用。消毒產品包括各種化學和非化學製劑，旨在破壞或惰性各種表面上的傳染性生物體。其中包括消毒劑、滅菌劑和防腐劑，用於醫療設備、醫院病床和其他高接觸區域，以保持無菌環境並最大限度地降低感染傳播的風險。手部衛生產品對於對抗 HAI 至關重要，因為手部感染是感染傳播的主要途徑。此類別包括抗菌洗手液、洗手液和消毒劑，其配方可有效殺死細菌並防止有害細菌在醫護人員、患者和訪客的手上繁殖。個人防護工具(PPE) 是保護醫護人員和病患免於接觸傳染源的服裝和裝備。個人防護裝備包括口罩、罩衣、面罩等，可作為防止感染疾病傳播的屏障。個人防護裝備至關重要，尤其是在高傳染性疾病爆發期間，有助於減少醫院感染的傳播並保護醫療機構中個人的健康。滅菌設備，包括高壓釜、熱滅菌器和冷滅菌器，對於醫療器械和醫療設備的無病原體至關重要。循環時間、容量和能源效率等因素將決定您的偏好。

最終使用者醫院和 ICU 重視針對高風險環境的全面自動化解決方案。

門診手術和診斷中心的特點是為手術和診斷程序提供短期患者護理。由於患者吞吐量高且週轉時間短，這些中心的 HAI 控制需求主要集中在高效的滅菌設備和方法上。醫院和加護病房（ICU）是治療重症患者的中心設施，預防醫院感染至關重要。這些設施需要全面的感染控制解決方案，包括空氣過濾、表面消毒和嚴格的滅菌通訊協定。儘管療養院和婦產中心的患者人口統計不同，但他們通用擔心患者容易感染 HAI。這些環境中的感染控制強調溫和而有效的消毒方法和可安全長期接觸的產品。

區域洞察

以美國和加拿大為代表的美洲地區由於嚴格的監管標準和高水準的醫療保健支出，對 HAI 緩解解決方案表現出強勁的需求。創新和技術進步是關鍵因素，重點是無毒環保的消毒方法和智慧監控系統。在歐盟 (EU)，嚴格的法規以及對醫療保健認證和品質的關注正在推動對高品質 HAI 管理解決方案的需求。這項歐盟範圍內的舉措旨在協調感染控制實踐，加強醫院感染研究的跨國合作並促進創新。中東的醫療保健正在經歷轉型，在醫院基礎設施和品質改進計劃方面進行了大量投資。對先進感染控制技術的需求不斷成長，一些國家更喜歡具有成本效益的解決方案。由於醫療基礎設施的成長和感染預防通訊協定意識的提高，亞太地區有望快速採用先進的醫院感染管理解決方案。中國和日本是亞太地區在研發方面投入大量資金的重要國家，而印度由於醫院數量不斷增加以及對醫療保健品質的重視，正在成為一個重要的市場。該地區的客戶購買行為傾向於提供成本效益和有效性的整合解決方案。

FPNV定位矩陣

FPNV定位矩陣對於評估醫院感染控制市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對醫院感染控制市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.醫院感染控制市場的市場規模與預測是多少？

2.在醫院感染控制市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3.醫院感染控制市場的技術趨勢和法規結構是什麼？

4.醫院感染控制市場主要廠商的市場佔有率為何？

5.進入醫院感染控制市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療機構對感染的認知不斷提高，感染控制政策變得越來越重要。
      • 隨著人口老化的加劇，慢性病盛行率也隨之增加
      • 醫療保健行業中消毒劑和醫用不織布的使用增加
    • 抑制因素
      • 與內視鏡再處理設備和微生物檢測設備相關的高成本
    • 機會
      • 加大研發投入，增加醫院耗材使用量
      • 滅菌消毒製程和感染控制設備的技術進步
    • 任務
      • 對再處理儀器安全性的擔憂
  • 市場區隔分析
    • 類型：診斷和測試設備的持續技術進步以提高效率
    • 最終使用者：醫院和 ICU 重視針對高風險環境的全面且自動化的解決方案。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章醫院感染控制市場：按類型

  • 診斷和測試設備
  • 消毒產品
  • 手部衛生產品
  • 個人防護設備
  • 消毒器

第7章 醫院感染控制市場適應症

  • 血流感染疾病
  • 困難梭狀桿菌感染疾病
  • 院內肺炎
  • 多重抗藥性細菌
  • 手術部位感染
  • 尿道感染

第8章醫院感染控制市場：依最終用戶分類

  • 門診手術/診斷中心
  • 醫院及重症監護室
  • 療養院和產科中心

第9章北美和南美醫院感染控制市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫院感染控制市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲醫院感染控制市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Alstrom 推出新一代同步滅菌套件“Reliance Fusion”
    • PAMA推出新型環氧乙烷消毒溶液
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-035590447FE4

[194 Pages Report] The Hospital Acquired Infection Control Market size was estimated at USD 34.26 billion in 2023 and expected to reach USD 36.39 billion in 2024, at a CAGR 6.48% to reach USD 53.20 billion by 2030.

Hospital acquired infection (HAI) control refers to the systematic approach and dedicated efforts undertaken by healthcare institutions to prevent and manage infections acquired by patients during their stay in hospitals & other healthcare facilities. These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 34.26 billion
Estimated Year [2024] USD 36.39 billion
Forecast Year [2030] USD 53.20 billion
CAGR (%) 6.48%

Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency

Diagnostic and testing equipment constitute critical components in the identification and management of hospital-acquired infections (HAIs). This segment includes devices and kits used for the rapid detection of pathogens in clinical settings. Leveraging advanced technologies, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), this equipment helps in the early diagnosis and monitoring of infections, enabling timely intervention and treatment. Disinfection products play a pivotal role in preventing the spread of infections within healthcare facilities. Disinfection products encompass a wide range of chemical and non-chemical agents designed to destroy or inactivate infectious organisms on various surfaces. Among these are disinfectants, sterilants, and antiseptics, which are used on medical equipment, hospital beds, and other high-touch areas to maintain a sterile environment and minimize the risk of infection transmission. Hand hygiene products are essential in the battle against HAIs, given that hand transmission is a major pathway for the spread of infections. This category includes antibacterial hand washes, hand rubs, and sanitizers, which are formulated to effectively kill germs and prevent the colonization of harmful bacteria on the hands of healthcare workers, patients, and visitors. Personal Protective Equipment (PPE) consists of garments and gear designed to protect healthcare workers and patients from being exposed to infectious agents. PPE includes items such as masks, gowns, and face shields, which act as barriers to the transmission of infections. Especially crucial during outbreaks of highly contagious diseases, PPE is instrumental in reducing the spread of HAIs and safeguarding the health of individuals within the healthcare environment. Sterilization equipment encompasses autoclaves, heat sterilizers, and low-temperature sterilizers, crucial for rendering medical instruments and devices pathogen-free. Factors such as cycle time, capacity, and energy efficiency govern their preference.

End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments

Ambulatory surgical & diagnostic centers are characterized by their short-term patient care for surgical and diagnostic procedures. The need for HAI control in these centers focuses on efficient sterilization equipment and practices, given the high throughput of patients and the necessity for quick turnaround times. Hospitals and Intensive Care Units (ICUs) are the epicenters for treating critical patients, making HAI prevention paramount. These facilities require comprehensive infection control solutions that encompass air filtration, surface disinfection, and stringent sterilization protocols. Nursing homes and maternity centers, while differing in patient demographics, share concerns over the vulnerability of their populations to HAIs. Infection control in these settings emphasizes gentle yet effective disinfection methods and products that are safe for long-term exposure.

Regional Insights

The Americas, led by the United States and Canada, exhibit a robust demand for HAI control solutions, attributed to stringent regulatory standards and a high level of healthcare expenditure. Innovation and technological advancement are key factors, with a focus on non-toxic, eco-friendly disinfection methods and smart monitoring systems. In the European Union, stringent regulations and a focus on accreditation and quality in healthcare drive the demand for high-standard HAI control solutions. EU-wide initiatives aim at harmonizing infection control practices, enhancing cross-border cooperation in HAI research, and fostering innovation. The Middle East is witnessing a healthcare transformation, with significant investments in hospital infrastructure and quality improvement initiatives. There is an increasing demand for advanced infection control technologies, albeit with a preference for cost-effective solutions in some countries. The Asia Pacific region is noted for its rapid adoption of advanced HAI control solutions, driven by growing healthcare infrastructure and heightened awareness of infection-prevention protocols. China and Japan are prominent countries in APAC with substantial investments in R&D, while India is emerging as a substantial market due to its increasing number of hospitals and focus on healthcare quality. Customer purchasing behavior in this region leans towards integrated solutions offering both cost efficiency and effectiveness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hospital Acquired Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hospital Acquired Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Diagnostic & Testing Equipment
    • Disinfection Products
    • Hand Hygiene Products
    • Personal Protective Equipment
    • Sterilization Equipment
  • Indication
    • Bloodstream Infections
    • Clostridioides difficile Infections
    • Hospital-acquired Pneumonia
    • Multidrug-Resistant Organisms
    • Surgical Site Infections
    • Urinary Tract Infections
  • End-user
    • Ambulatory Surgical & Diagnostic Centers
    • Hospitals & ICUs
    • Nursing Homes & Maternity Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hospital Acquired Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hospital Acquired Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Hospital Acquired Infection Control Market?

4. What is the market share of the leading vendors in the Hospital Acquired Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Hospital Acquired Infection Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
      • 5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
      • 5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
      • 5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the safety of reprocessed instruments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
    • 5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Hospital Acquired Infection Control Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Testing Equipment
  • 6.3. Disinfection Products
  • 6.4. Hand Hygiene Products
  • 6.5. Personal Protective Equipment
  • 6.6. Sterilization Equipment

7. Hospital Acquired Infection Control Market, by Indication

  • 7.1. Introduction
  • 7.2. Bloodstream Infections
  • 7.3. Clostridioides difficile Infections
  • 7.4. Hospital-acquired Pneumonia
  • 7.5. Multidrug-Resistant Organisms
  • 7.6. Surgical Site Infections
  • 7.7. Urinary Tract Infections

8. Hospital Acquired Infection Control Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical & Diagnostic Centers
  • 8.3. Hospitals & ICUs
  • 8.4. Nursing Homes & Maternity Centers

9. Americas Hospital Acquired Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hospital Acquired Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hospital Acquired Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
    • 12.3.2. PAMA introduces new ethylene oxide sterilisation solution
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
  • FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 296. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023